ResearcherDüsseldorf University HospitalActive in the last 2 years

Anne T. Schneider

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1902-4139; OpenAlex author ID A5086169631. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 14

Papers, trials and grants by year

2025: 1 paper

Papers 1

A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development. Co-author DOI 10.1038/s41467-025-56493-7 ↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Marina Lesina · 1 shared paper, 2025 · strength 0.16
- Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7 ↗
Aristeidis Papargyriou · 1 shared paper, 2025 · strength 0.16
- Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7 ↗
Thilo Hackert · 1 shared paper, 2025 · strength 0.16
- Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7 ↗
Maximilian Reichert · 1 shared paper, 2025 · strength 0.16
- Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7 ↗
Henrik Einwächter · 1 shared paper, 2025 · strength 0.16
- Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7 ↗
Matthias M. Gaida · 1 shared paper, 2025 · strength 0.16
- Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7 ↗
Wolfram Trudo Knoefel · 1 shared paper, 2025 · strength 0.16
- Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7 ↗
Roland Michael Schmid · 1 shared paper, 2025 · strength 0.16
- Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7 ↗
Sebastian Mueller · 1 shared paper, 2025 · strength 0.16
- Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7 ↗
Roland Rad · 1 shared paper, 2025 · strength 0.16
- Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7 ↗
Valentina Leone · 1 shared paper, 2025 · strength 0.16
- Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7 ↗
Iréne Esposito · 1 shared paper, 2025 · strength 0.16
- Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7 ↗
Tom Luedde · 1 shared paper, 2025 · strength 0.16
- Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7 ↗
Hana Algül · 1 shared paper, 2025 · strength 0.16
- Paper A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic canc… DOI 10.1038/s41467-025-56493-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.